Pharmaceutical company 3Z raises $400K seed round
3Z pharmaceuticals has closed a $400K seed round. The investors were Swiss biotech companies Baliopharm and Probiocon, as well as previous investors NSA Ventures and Sigþór Sigmarsson.
“3Z offers a unique technology to speed up the development of innovative drugs for the treatment of all kind of neurological disorders,” says